Drug-induced lung disease: 1990 review.
Numerous drug-induced pulmonary manifestations have been reported but studies of their pathogenic mechanisms are still rare. These mechanisms should, however, be precisely determined in order to identify subjects at risk and to prevent some of these complications by the proper use of certain drugs in more appropriate conditions. The possibility of an iatrogenic manifestation should always be considered in patients developing pulmonary symptoms. Data from biological investigations, although not specific, contribute to the understanding of lung injury mechanisms.
Israel-Biet
D
D
Université René Descartes, Hôpital Laënnec, Paris, France.
Labrune
S
S
Huchon
G J
GJ
D001249:Asthma / Q000139:chemically induced; D004342:Drug Hypersensitivity; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D007049:Iatrogenic Disease; D008171:Lung Diseases / Q000139:chemically induced*; D010995:Pleural Diseases / Q000139:chemically induced; D011654:Pulmonary Edema / Q000139:chemically induced; D011655:Pulmonary Embolism / Q000139:chemically induced; D011658:Pulmonary Fibrosis / Q000139:chemically induced